Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer

The MAP kinase and NF-κB signaling pathways play an important role in thyroid cancer tumorigenesis. We aimed to examine the therapeutic potential of dually targeting the two pathways using AZD6244 and Bortezomib in combination. We evaluated their effects on cell proliferation, cell-cycle progression...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Lett
Main Authors: Tsumagari, Koji, Abd Elmageed, Zakaria Y., Sholl, Andrew B., Friedlander, Paul, Abdraboh, Mohamed, Xing, Mingzhao, Boulares, A. Hamid, Kandil, Emad
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4555189/
https://ncbi.nlm.nih.gov/pubmed/26208433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2015.07.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados